BCIS ACI 2020: TAVI Should Now Be the Default Treatment for Patients with Symptomatic Aortic Stenosis

Published: 13 March 2020

  • Views:

    Views Icon 317

  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 4
    Panel Discussion
    Clare Appleby, Simon Redwood, Gregg Stone, Andrew SP Sharp, Rob Butler, Marjan Jahangiri
    Up Next
Average (ratings)
No ratings
Your rating

Overview

In this video series chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate. Further through the series Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach whilst Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis. The series concludes with the panel and chairs reflecting on the data and recent arguments delivered. 

This content was provided by the courtesy of BCIS.

More from this programme

Part 1

Introduction and preliminary poll

Chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate.
1 session
Introduction and preliminary poll Watch now

Part 2

Pro Argument

Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach in the treatment of patients with symptomatic aortic stenosis.
1 session
Pro Argument Watch now

Part 3

Contra Argument

Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis.
1 session
Contra Argument Watch now

Part 4

Panel Discussion

The panel and the chairs conclude the debate by reflecting on recent data and the arguments delivered by Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) and Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK).
1 session
Panel Discussion Watch now

Faculty Biographies

Clare Appleby

Clare Appleby

Dr Clare Appebly is an interventional cardiologist at Liverpool Heart and Chest Hospital, Liverpool, UK. Dr Appleby is an Honorary Secretary of the British Cardiovascular Intervention Society (from Jan 2020).

View full profile
Simon Redwood

Simon Redwood

Senior Lecturer and Consultant Interventional Cardiologist

Simon Redwood is a Senior Lecturer and Consultant Interventional Cardiologist at St Thomas’ Hospital, London. He is also Lead Clinician for Research and Development within the Directorate and a Council Member of the British Cardiovascular Interventional Society (BCIS).

 

 

View full profile
Gregg Stone

Gregg Stone

Professor of Medicine, Professor of Population Health Sciences and Policy, and Director of Academic Affairs

Dr Stone is a leading expert in interventional cardiology and is one of the most widely cited researchers in science. He has served as the principal investigator for approximately 130 national and international multicentre randomised trials, has delivered thousands of lectures internationally, and has authored more than 2,500 book chapters, manuscripts and abstracts published in peer-reviewed literature.

Dr Stone is the Director of Academic Affairs for Mount Sinai Heart Health System, and Professor of Medicine and Professor of Population Health Sciences and Policy at The Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine, at Mount Sinai, New York.

Dr Gregg Stone is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

View full profile
Andrew SP Sharp

Andrew SP Sharp

Consultant Cardiologist

Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.

Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.

Andrew's specialist interests include the pharmacological and interventional…

View full profile
Rob Butler

Rob Butler

Dr Butler was appointed in 2003, he works in a major regional cardiac centre in Stoke-On-Trent, where the catchment for tertiary cardiology is nearly 2 million people across Staffordshire, Shropshire and Cheshire.

A substantial amount of his workload is treating angina and heart attack patients.

View full profile
Marjan Jahangiri

Marjan Jahangiri

Marjan Jahangiri, FRCS, is professor of cardiac surgery at St George's Hospital, University of London. She was the first woman in Europe to be appointed as a professor of cardiac surgery.

Dr Marjan Jahangiri is on the Editorial Board of European Cardiology Review.

View full profile